下载掌阅APP，畅读海量书库
立即打开
［1］REDDY K R，BEAVERS K L，HAMMOND S P，et al. American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy ［J］. Gastroenterology，2015，148（1）：215-219.
［2］PERRILLO R P，GISH R，FALCK-YTTER Y T. American Gastroenterological Association Institute technical review on prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy ［J］. Gastroenterology，2015，148（1）：221-244.
［3］EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection ［J］. J Hepatol，2017，67（2）：370-398.
［4］AMERICAN COLLEGE OF RHEUMATOLOGY AD HOC GROUP ON USE OF SELECTIVE AND NONSELECTIVE NONSTEROIDAL ANTIINFLAMMATORY DRUGS. Recommendations for use of selective and nonselective nonsteroidal antiinflammatory drugs：an American Collegeof Rheumatology white paper ［J］. Arthritis Rheum，2008，59（8）：1058-1073.
［5］中华医学会肝病学分会，中华医学会感染病学分会.慢性乙型肝炎防治指南（2015更新版）［J］.中华肝脏病杂志，2015，23（12）：888-905.
［6］依那西普治疗类风湿关节炎和强直性脊柱炎专家组.依那西普治疗类风湿关节炎和强直性脊柱炎的专家建议（2013）［J］.中华医学杂志，2013，93（18）：1363-1369.
［7］英夫利西单抗使用参考意见专家组.英夫利西单抗治疗类风湿关节炎和强直性脊柱炎的参考意见［J］.中华内科杂志，2012，51（12）：1011-1016.
［8］CASO F，CANTARINI L，MORISCO F，et al. Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection ［J］. Expert Opin Biol Ther，2015，15（5）：641-650.
［9］YLLMAZ N，KARADAĞ Ö，KIMYON G，et al. Prevalence of hepatitis B and C infections in rheumatoid arthritis and ankylosing spondylitis：A multicenter countrywide study ［J］. Eur J Rheumatol，2014，1（2）：51-54.
［10］SINGH J A，SAAG K G，BRIDGES S L JR，et al. American college of rheumatology. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis ［J］. Arthritis Care Res（Hoboken），2016，68（1）：1-25.